Optimization of three-dimensional T2-weighted image sequences in female pelvic magnetic resonance imaging
Physical and Engineering Sciences in Medicine · 2025
DOI: 10.1007/s13246-025-01549-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical and Engineering Sciences in Medicine, 2025. Verfasst von Yasuo Takatsu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Major in Medical Sciences, Graduate School of Medical Sciences, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-119…. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Imaging, Three-Dimensional, Pelvis. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
This study aimed to characterize T2-weighted fast spin-echo three-dimensional (3D) magnetic resonance images (MRI) by using variable refocusing angle (VRFA) in female pelvic organs and to extract clinically relevant parameters. A 3T MRI system was used, and contrast-to-noise ratio (CNR) and full width at half maximum (FWHM) were calculated using a phantom mimicking the uterine three-layered structure to confirm the characteristics of low-constant VRFA (LC-VRFA) and tissue-specific VRFA (TS-VRFA) under changing parameters. Parameters that were relatively well-evaluated in the phantom study were combined and visually evaluated as an overall assessment by volunteer images, using common turbo spin-echo (TSE) coefficients and equivalent TE (TEequiv). In most combinations, CNR tended to be higher for longer TEequiv for each TSE factor for both LC- and TS-VRFA, but particularly higher with RFA of 60°-90°, TSE factor of 60-90, and TEequiv of 90-100 ms. TS-VRFA was high in the common TSE factor and TEequiv, with some exceptions. In all combinations, the FWHM of LC-VRFA was narrower than TS-VRFA (P < 0.01). For visual evaluation of volunteer images, LC-VRFA was higher than TS-VRFA (P < 0.05). In LC-VRFA, the upper combinations of RFA (°)-TSE factor-TEequiv (ms) were 90-80-100, 90-90-100, and 90-60-100, respectively. We characterized VRFA 3D T2-weighted MR images for female pelvic organs, extracted optimal parameters. The better VRFA was LC-VRFA, with RFA of 60°-90°, TSE factor of 60-90, and TEequiv of 90-100 ms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Major in Medical Sciences, Graduate School of Medical Sciences, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. yasuo.takatsu@fujita-hu.ac.jp.
- Department of Molecular Imaging, Clinical Collaboration Unit, School of Medical Sciences, Fujita Health University, 1-98, Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. yasuo.takatsu@fujita-hu.ac.jp.
- Division of Health Sciences, Graduate School of Medical Sciences, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, Ishikawa, 920-0942, Japan. yasuo.takatsu@fujita-hu.ac.jp.
- Medical Imaging Center of Manryoukai, 1-8-3, Sanno, Nishinari-ku, Osaka, 557-0001, Japan.
- Department of Radiology, Minoh City Hospital, 5-7-1 Kayano, Minoo-shi, Osaka, 562-0014, Japan.
- PD Business Marketing & Sales, Philips Japan, Philips bldg. 7F, Konan 2-13-37, Minato-ku, Philips, Tokyo, 108-8507, Japan.
Zitieren
APA
Takatsu, Y., Ikemoto, A., Yamashiro, T., Nakamura, M., & Miyati, T. (2025). Optimization of three-dimensional T2-weighted image sequences in female pelvic magnetic resonance imaging. Physical and Engineering Sciences in Medicine. https://doi.org/10.1007/s13246-025-01549-7
Vancouver
Takatsu Y, Ikemoto A, Yamashiro T, Nakamura M, Miyati T. Optimization of three-dimensional T2-weighted image sequences in female pelvic magnetic resonance imaging. Physical and Engineering Sciences in Medicine. 2025. doi:10.1007/s13246-025-01549-7
BibTeX
@article{Takatsu2025,
author = {Takatsu, Yasuo and Ikemoto, Atsushi and Yamashiro, Takanobu and Nakamura, Masanobu and Miyati, Tosiaki},
title = {Optimization of three-dimensional T2-weighted image sequences in female pelvic magnetic resonance imaging},
journal = {Physical and Engineering Sciences in Medicine},
year = {2025},
doi = {10.1007/s13246-025-01549-7}
}
EUVIMED